ArticleMusculoskeletal care2026
Patient Experiences and Preliminary Effects of Virtual Reality Based Pain Treatment in Rheumatoid Arthritis Patients With Persistent Pain Despite Low Disease Activity: A Mixed Method Pilot Study.
Article in Musculoskeletal care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to examine the acceptability, usability, patient perceptions and preliminary effects of a virtual reality (VR) based pain management programme for people with rheumatoid arthritis with persistent pain despite low disease activity.
methodsThis study used a two-phase mixed-methods approach with questionnaires and qualitative interviews. During the first phase of this study, 21 participants completed the virtual reality sickness questionnaire (VRSQ) and a 0-10 NRS pain before and after using the VR programme once. Semi-structured individual interviews were conducted on the perceptions of patients. In the second phase of the study, five participants used the VR programme for 8 weeks at home. Participants answered a NRS pain twice a week and the VRSQ, ASES and SF-36 before and after the experiment.
resultsIn the first phase, a clinically meaningful reduction in pain intensity was observed in 10% of participants after one session of VR. Virtual reality sickness symptoms worsened for some and improved in others. Participants found the programme usable. Patients perceived relaxing and distracting effects. In the second phase, the median NRS pain intensity decreased by one point. Quality of life appeared to improve in the physical domain, whereas self-efficacy remained stable. Virtual reality sickness symptoms remained stable or showed slight improvements overall.
conclusionThe VR-based pain management programme was considered acceptable and usable by most people with RA. The programme also tended to slightly reduce pain. A larger randomised controlled trial is needed to determine the effectiveness of the programme.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.